David Winchester to Combined Modality Therapy
This is a "connection" page, showing publications David Winchester has written about Combined Modality Therapy.
Connection Strength
0.342
-
Treatment differences at high volume centers and low volume centers in non-metastatic and metastatic adrenocortical carcinoma. Am J Surg. 2022 03; 223(3):582-586.
Score: 0.139
-
Sentinel node biopsy alone for node-positive breast cancer: 12-year experience at a single institution. J Am Coll Surg. 2011 Jul; 213(1):122-8; discussion 128-9.
Score: 0.066
-
Multidisciplinary treatment of primary melanoma. Surg Clin North Am. 2009 Feb; 89(1):267-81, xi.
Score: 0.057
-
Differences in the Impact of Age on Mortality in Well-Differentiated Thyroid Cancer. Ann Surg Oncol. 2018 Oct; 25(11):3193-3199.
Score: 0.027
-
Surgery and hormone therapy trends in octogenarians with invasive breast cancer. Am J Surg. 2016 Mar; 211(3):541-5.
Score: 0.023
-
Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes. Ann Surg Oncol. 2015 Dec; 22(13):4295-304.
Score: 0.022
-
The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy. Am J Surg. 2000 Jun; 179(6):446-52.
Score: 0.008